IE
CCEL icon

Israel Englander’s Cryo-Cell International CCEL Stock Holding History

Israel Englander’s Portfolio CCEL Stock Details CCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-12,741
Closed -$148K – 6947
2021
Q4 		$148K Buy
+12,741
New +$159K ﹤0.01% 6078

Other funds holding CCEL

ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCP
Seizert Capital Partners Birmingham, Michigan $2.42B AUM 22.12% 1-Year Est. Return
MCM
Maryland Capital Management Towson, Maryland $1.2B AUM 18.21% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Israel Englander's CCEL Position: Q1 2022 in Review

Israel Englander sold out of Cryo-Cell International (CCEL) in Q1 2022, closing a stake of 12,741 shares — an estimated $148K sold.

Israel Englander first reported a position in CCEL in Q4 2021 and held it in 1 quarter. The position peaked at $148K in Q4 2021. 12 funds tracked by Wall St. Rank hold CCEL as of Q1 2022.

  • Israel Englander reported no remaining Cryo-Cell International position as of Q1 2022 after selling out during the quarter.
  • Israel Englander sold 12,741 Cryo-Cell International shares in Q1 2022, an estimated $148K.
  • Israel Englander first reported a position in Cryo-Cell International in Q4 2021 and held it in 1 quarter.
  • Israel Englander's Cryo-Cell International position peaked at $148K in Q4 2021.
  • 12 funds tracked by Wall St. Rank held Cryo-Cell International as of Q1 2022.

Based on Millennium Management's 13F filing for Q1 2022, filed 16 May 2022.